BIO-Europe 2026 Attendees List & Exhibitors List

Name: BIO-Europe 2026
Start: 2026-11-09T08:00:00+00:00
End: 2026-11-11T17:00:00+00:00
Location: Koelnmesse (Cologne Convention Centre)

Looking for relevant contacts from BIO-Europe 2026?

The BIO-Europe 2026 exhibitors list and attendees list helps businesses reach biotechnology, pharmaceutical, and life science organizations. Contacts may include drug developers, biotech startups, investors, contract research and manufacturing organizations, and technology providers. You can use the list for outreach before, during, and after the event.

BIO-Europe 2026 runs from 09 to 11 November 2026 at Koelnmesse (Cologne Convention Centre) in Cologne, Germany. The event focuses on biopharma partnering, with program tracks on the business of biotech, regulatory and clinical strategy, therapeutic insights, and biomanufacturing. Attendees typically include C-suite executives, investors, and business development teams.

Get a Quote

Medical & Pharma Industry Community

Professionals & Decision-Makers

BIO-Europe 2026 draws Chief Executive Officers, Chief Business Officers, Business Development Directors, and Licensing Managers. Other attendees often include Venture Capital Partners, Chief Scientific Officers, Alliance Managers, and Technology Transfer Officers from biotech, pharma, and research institutions.

Key Medical & Pharma Segments Covered

Biotechnology Drug Development
Pharmaceutical Licensing and Partnering
Biologics and Biosimilars
Cell and Gene Therapy
Oncology Therapeutics
Contract Research Organizations (CRO)
Contract Development and Manufacturing (CDMO)
Diagnostics and Biomarkers
Life Science Venture Capital
Academic Technology Transfer

Technologies Driving Innovation

Organizations at BIO-Europe 2026 typically present drug candidates, therapeutic platforms, and enabling technologies available for licensing or co-development. Topics may include cell and gene therapies, antibody and biologics platforms, AI-driven drug discovery, and biomanufacturing services.

Market Connections & Growth Opportunities

The contact list helps B2B teams identify licensing partners, investors, and service buyers across the biopharma value chain. Sales and business development teams can use it to plan partnering meetings, prioritize accounts, and follow up with qualified prospects after the event.

BIO-Europe 2026 Contact Database

The BIO-Europe 2026 contact database covers organizations and professionals connected to biotechnology, pharmaceutical development, and life science investment. Records may include exhibitors, attendees, and related industry stakeholders. Fields are included where available and lawfully sourced.

Business Data Available

Company Name
Key Contacts, including Chief Executive Officers, Chief Business Officers, Business Development Directors, Licensing and Alliance Managers, Chief Scientific Officers, Heads of R&D, Regulatory Affairs Directors, Clinical Development Directors, Venture Capital Partners, and Technology Transfer Managers
Business Email Addresses & Professional Contact Information, where available and lawfully sourced
Industry and Solution Categories
Company Type and Business Classification
Organization Location and Regional Market Information

Profiles can be segmented by job function, therapeutic area, company type, and region for focused outreach.

First Name

Last Name

Business Email Id

Phone Number

Company Name

Title

Web Address

Industry

City

State

Country

Postal

LinkedIn Profile on Request

Event Details

Medical & Pharma Buyer & Influencer Profiles

Buyers and influencers at BIO-Europe 2026 hold scientific, commercial, and investment roles across biotech and pharmaceutical organizations.

Typical business profiles include:

Business Development Directors evaluating in-licensing candidates, co-development deals, and partnership terms.
Chief Scientific Officers and R&D Heads evaluating therapeutic platforms, preclinical data, and research collaborations.
Venture Capital and Corporate Investors evaluating early-stage biotech companies, funding rounds, and portfolio fit.
Outsourcing and Procurement Managers evaluating CRO, CDMO, and biomanufacturing service providers.

Together, these roles shape each stage of the buying process, from scouting assets and technical due diligence to negotiating terms and signing agreements.

Streamline your marketing efforts by customizing contacts based on criteria like:

Unlocking Opportunities Through BIO-Europe 2026 Contacts

BIO-Europe 2026 contacts help businesses find the people who drive biopharma partnering and investment decisions. The data supports research, account planning, and outreach to organizations that match your offering. You can use it to connect with relevant teams before, during, and after the event in Cologne.

Locate Industry Influencers

Find chief business officers, business development directors, and R&D heads who shape licensing, partnering, and pipeline decisions across biotech and pharmaceutical companies.

Engage Technical Communities

Reach scientists, clinical development leads, and regulatory specialists working on biologics, cell and gene therapies, and other therapeutic modalities across the life science sector.

Discover Partnership Paths

Identify biotech companies, pharma licensees, and research institutions that may be open to licensing deals, co-development agreements, or research collaborations.

Understand Technology Demand

Review which organizations attend and present to gauge interest in therapeutic platforms, drug discovery tools, biomanufacturing capacity, and outsourced research services.

Refine Outreach Segments

Group contacts by job role, therapeutic area, company type, development stage, and region to build focused campaigns for each audience in the biopharma market.

Evaluate Market Landscape

Map exhibitors and attending organizations to understand competitors, potential partners, investors, and service providers active in the biotechnology and pharmaceutical market.

Looking for Event Editions or Post-Event Attendees List?

Get access to both past and upcoming event editions, complete with verified post-event attendee and exhibitor lists. These lists are curated to include accurate contact details of key decision-makers, industry professionals, and exhibiting companies.

Contact List Opt-In Process

When starting a marketing campaign, ensure you leverage an opt-in contact list. This list consists of the contact details of individuals who explicitly agree to receive messages from you.

Step 1

Data Sourcing

The Data is collected manually through multiple online and offline global subscriptions, including e-books, tradeshows, news agencies, directories, web journals, and more, to gather relevant information.

Step 2

Data Appending

The missing fields in the collected data are appended and verified using our patent machine learning tools to compile and segment the contact list.

Step 3

Data Validation

To validate contact records, a thorough scanning process is conducted to match them against our master database. This is followed by a manual verification process, where records are reviewed and validated through relevant social media platforms to ensure authenticity.

Step 4

Data Cleansing

Statistical and analytical techniques are employed to identify anomalies in the data. Once the dataset is thoroughly reviewed, the data cleaning process is initiated. A manual verification is then performed and cross-checked with social media platforms to ensure authenticity.

Step 5

Data Accuracy

After the cleaning workflow, the data is inspected for accuracy. Our Data analysts identify records that require manual repair, and the cycle of validation, verification, and cleaning is then repeated.

Step 6

Email Campaigns for Consent

A/B tested OPT-IN email campaigns are conducted to obtain and validate user consent, ensuring compliance with global data protection regulations, including CAN-SPAM and GDPR.

Step 7

Tele-verification & Opt-out Campaign

The final compiled list undergoes opt-out email campaigns followed by tele-verification to confirm consent for all data fields.

Ways Businesses Can Utilize Visitor Insights

Reach Specialized Audiences

Connect with business development, licensing, and R&D professionals who focus on biotech and pharmaceutical partnering rather than general healthcare or consumer audiences.

Connect Solutions With Needs

Match your offering, such as contract research, biomanufacturing, regulatory consulting, or lab technology, with organizations whose development programs align with what you provide.

Develop Strategic Lists

Build account lists of biotech developers, pharma licensees, investors, and service providers, prioritized by role, therapeutic area, company type, and region for sales planning.

Create Meaningful Connections

Start informed conversations with scientific and commercial leaders by referencing their therapeutic focus, development stage, and partnering interests before reaching out.

Why BIO-Europe 2026 Contacts Matter

Strengthen Medical & Pharma Targeting

Focus outreach on biotech, pharma, and life science professionals linked to BIO-Europe 2026, and spend less time on contacts outside your target market.

Engage Before the Event

Schedule partnering meetings, product presentations, and follow-up calls with relevant attendees ahead of the event to make better use of time in Cologne.

Identify Growth Opportunities

Spot new licensing partners, investors, customers, and emerging therapeutic areas across the biopharma market to support pipeline growth after the event.

Datasets for Similar Events

BIO-Europe 2026

ANESTHESIOLOGY 2026

Abu Dhabi Future Health Summit 2026

Dental World Budapest 2026

China Dental Show – CDS 2026

San Antonio Breast Cancer Symposium 2026

Events Lists by Country

Testimonials: What Our Clients Are Saying

“I can’t recommend VisitorsList enough. Their attendee list was pivotal for our event success, allowing us to pinpoint our target audience with precision.”

“As an exhibitor, I’m delighted to endorse VisitorsList. and their attendee data helped us connect with relevant prospects efficiently, making our investment worthwhile.”

“VisitorsList has been our go-to for attendee lists. Their accurate data and stellar support ensure our events run smoothly every time.”

“VisitorsList’s exhibitor list empowered us to strategize effectively for our trade show appearances. Their accurate and well-structured data helped us identify the right prospects, prioritize outreach, and plan meaningful interactions ahead of the event. With reliable insights and clear information, our team saved valuable time and achieved better engagement, making each exhibition far more productive and results-driven.”

“Having worked in event planning for years, I confidently vouch for VisitorsList. Their attendee data exceeded my expectations, providing accurate and actionable insights that made our planning process smoother and more efficient. The well-organized information helped us target the right audience, improve engagement strategies, and maximize event outcomes, making VisitorsList a truly valuable partner for successful event execution.”

I’ve worked with VisitorsList on four occasions, primarily for conference-related contacts, and they’ve consistently been great partners. They’re flexible with budgets, offering discounts when possible, and can expedite delivery timelines. They’re also very accommodating with custom data or list requests. The data they’ve provided has been highly useful for the targeted outreach we conduct.

“VisitorsList’ exhibitor list provided us with invaluable insights for our trade show strategy, helping us make meaningful connections and drive business growth.”

Build Connections Across the Medical & Pharma Ecosystem

Whether you offer contract research services, biomanufacturing capacity, drug discovery platforms, regulatory consulting, clinical trial services, laboratory equipment, or life science data tools, the BIO-Europe 2026 contact database helps you find relevant B2B audiences in the biopharma market.

Frequently Asked Questions

Which Medical & Pharma Areas Are Covered?

The list covers biotechnology and pharmaceutical areas linked to BIO-Europe 2026. This may include drug development, licensing and partnering, biologics, cell and gene therapy, contract research and manufacturing, and life science investment.

Who Can Businesses Connect With?

Businesses can connect with commercial, scientific, and investment decision-makers in biopharma. Contacts may include chief business officers, business development directors, R&D heads, licensing managers, and venture capital partners, where available.